Main competitors
Consensus Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Objective/dr gap Nbr of analysts
2,047.35 +9.23%34
12,900 +18.68%12
1,463.62 +1.79%37
1,074.17 -2.29%30
227.65 -13.11%6
2,483.33 +5.67%12
2,496.5 +14.49%10
- - - - -
3,303.29 +1.46%14
150.5 -0.79%4
15.42 +90.94%5
164.24 +1.7%3
- - - 124.25 -6.79%1
- - 20.6 +28.51%1
- - - - -
- - - - -
- - - - -
Average 2,036.22 +11.50% 13
Weighted average by Cap. 4,251.64 +9.74% 21
Generic Pharmaceuticals